Publication | Closed Access

Haploidentical IL-15/41BBL activated and expanded natural killer cell infusion therapy after salvage chemotherapy in children with relapsed and refractory leukemia

Hematological MalignancySalvage ChemotherapyCell TherapyOncologyPediatric HematologyImmunologyHematologyRefractory LeukemiaHaploidentical Il-15/41bblImmunotherapyMedicineNatural Killer Cells